史赛克
SYK
294.66
+1.43
+0.49%
史赛克
US · SYK
#199 按市值排名
上市于 1970
294.66
+1.43
+0.49%
实时 - 追踪5344个代码 - 心跳于401秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了11家。
- 机构持股总比例下降了0.5个百分点。
机构持股
- 机构持股比例
- 81.87% -0.55pp
- 机构数量
- 2,643 -11
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund68.22%
Individual/Insider9.14%
Public Company4.93%
Private Company2.77%
Government Pension Fund1.68%
Sovereign Wealth Fund1.33%
Hedge Fund1.21%
Family Office/Trust0.75%
Corporate Pension Plan0.34%
Other9.62%
主要股东 截至 2026-06-30
BlackRock
7.15% · 27.41M 股
Vanguard Capital Management, LLC
6.38% · 24.47M 股
John Brown
5.23% · 20.06M 股
State Street Global Advisors
4.05% · 15.53M 股
Greenleaf Trust National Association
3.97% · 15.23M 股
Other
73.22%
Ronda Stryker
3.77% · 14.47M 股
J.P. Morgan Asset Management, Inc.
3.28% · 12.59M 股
T. Rowe Price Group, Inc.
3.11% · 11.93M 股
Vanguard Portfolio Management, LLC
2.13% · 8.17M 股
Wellington Management Group
2.13% · 8.17M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 14次买入 · 30次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| John Brown | Former Chairperson | 5.23% |
| Ronda Stryker | Independent Director | 3.77% |
| Kevin Lobo | Chairperson & CEO | 0.06% |
| J. Pierce | Group President of MedSurg & Neurotechnology | 0.02% |
| Spencer Stiles | Group President of Orthopaedics & Spine | 0.02% |
| Yin Becker | VP of Communications, Public Affairs & Corporate Marketing and Chief Corporate Affairs Officer | 0.01% |
| Viju Menon | Group President of Global Quality & Operations | 0.00% |
| Allan Golston | Independent Director | 0.00% |
| Dylan Crotty | President of Instruments | 0.00% |
| Glenn Boehnlein | VP & CFO | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-23 | Preston Wells | VP & Group CFO of Orthopaedics and Spine | Other Disposition | -109 | -- |
| 2026-09-21 | Preston Wells | VP & Group CFO of Orthopaedics and Spine | Other Disposition | -2,738 | -- |
| 2026-08-31 | Emily Baculik | Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-08-20 | Dylan Crotty | President of Instruments | Open Market Disposition | -441 | $328.61 |
| 2026-08-18 | Ronda Stryker | Independent Director | Open Market Disposition | -350,000 | $331.74–343.47 |
| 2026-08-17 | Ronda Stryker | Independent Director | Intent to Sell (Form 144) | -350,000 | $335.00 |
| 2026-08-17 | Debra King | VP, Chief Digital & Information Officer | Open Market Disposition | -826 | $336.30 |
| 2026-07-31 | M. Fink | VP & Chief Human Resources Officer | Sale to Issuer | -111 | $325.70 |
| 2026-07-31 | Robert Fletcher | VP & Chief Legal Officer | Sale to Issuer | -94 | $325.70 |
| 2026-07-31 | Debra King | VP, Chief Digital & Information Officer | Sale to Issuer | -533 | $325.70 |
| 2026-07-31 | Kimberly Montagnino | -- | Sale to Issuer | -155 | $325.70 |
| 2026-05-31 | Spencer Stiles | Group President of Orthopaedics & Spine | Other Disposition | -1,607 | -- |
| 2026-05-27 | Robert Fletcher | VP & Chief Legal Officer | Automatic Disposition | -4,544 | $304.23–310.22 |
| 2026-05-25 | Ronda Stryker | Independent Director | Open Market Disposition | -310,000 | $310.77–315.11 |
| 2026-05-10 | M. Fink | VP & Chief Human Resources Officer | Derivative Exercise and Sale | -21,582 | $154.14–294.23 |
| 2026-05-10 | M. Fink | VP & Chief Human Resources Officer | Open Market Disposition | -3,500 | $283.45 |
| 2026-05-05 | Lisa Skeete Tatum | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Ronda Stryker | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Mary Brainerd | Independent Director | Other Acquisition | +762 | -- |
| 2026-05-05 | Sherilyn S. McCoy | Lead Independent Director | Other Acquisition | +762 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:20 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
史赛克 讨论区 0 条评论